FDA Approved Uses of Cabozantinib
September 20, 2019
Most recently, the FDA approved cabozantinib for the treatment of HCC, but this drug has a history.
Jennifer Leavitt, MS
The Microbiome and Colorectal Cancer: Current Clinical Trials
February 15, 2019
Here, we look at the currently open and recruiting clinical trials that focus on the role of the microbiome in colorectal cancer.
Oncology Conference Highlights, Q4
January 17, 2019
Our team reviews 2018 conference highlights in oncology care, including studies from ASH, SABCS, and SIO.
Key Advances in Oncology, 2018
January 17, 2019
Our team reviews the most important advances in oncology in 2018, including those in breast cancer, hematologic cancers, lung cancer, immunotherapy, and more.
